WHO ICTRP trial
Perilla frutescens extract on degenerative arthritis
KCT0002175 · Clinical Research Information Service (CRIS) · Recruiting
Key facts
| Trial ID | KCT0002175 |
|---|---|
| Public title | Perilla frutescens extract on degenerative arthritis |
| Scientific title | 12 weeks, ramdomized, double-blind, placebo-controlled crinical trial for the evaluation of the efficacy and safety of complex of Perilla frutescens extract on degenerative arthritis |
| Primary sponsor | Korea Atomic Energy Research Institue |
| Registry | Clinical Research Information Service (CRIS) |
| Recruitment status | Recruiting |
| Study type | Interventional Study |
| Phase | Not applicable |
| Countries | Korea, Republic of |
| Conditions | Diseases of the musculo-skeletal system and connective tissue |
| Interventions | Dietary Supplement : take a 1000 mg capsule of active medication(containing 250 mg of Perilla frutescens extract complex in a capsule) or soybeen oil 1capsule though randomaization twice daily for 12 weeks. |
| Registration date | Dec 23, 2016 |
| Target size | 84 |
| Registry page | cris.nih.go.kr |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: